Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00341159 · ClinicalTrials.gov registry record
Analysis of Data From the Women's Contraceptive and Reproductive Experiences (CARE) Study
A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).
- Completed
- Registry status
- 9,257
- Enrollment target
NCT00341159 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 9,257 participants.
The verdict
NCT00341159 has completed, sponsored by National Human Genome Research Institute (NHGRI).
- COMPLETED
- Registry status
- 9,257 participants
- Enrollment target
Study Summary
This study will continue to analyze data collected by the Women's Contraceptive and Reproductive Experiences (CARE) study. The CARE study was designed to evaluate the association between reproductive factors and risk of breast cancer in white and African-American women in the United States. The present study is not recruiting additional participants. The original study enrolled 4,575 women with breast cancer and 4,682 control subjects between 35 and 64 years of age All participants provided a blood sample for genetic study. The samples were analyzed for variants (mutations) in the BRCA1 and BRCA2 genes, the vitamin D receptor gene, the androgen receptor gene, and the insulin-like growth factor-1 gene. In addition, all participants were interviewed to obtain information related to breast cancer risk, including a history of reproductive, menstrual, oral contraceptive, and hormone replacement therapy use; lifestyle factors such as smoking, alcohol use, body weight, and physical activity; history of medical conditions and procedures; demographic characteristics, such as age, race, marital status, and so forth; and a detailed family history of cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9,257 participants |
| Start Date | 2005-01-18 |
| Est. Completion | 2015-02-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00341159
The ClinicalTrials.gov registry entry for NCT00341159 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 9,257 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Human Genome Research Institute (NHGRI), which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00341159 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00341159 about?
NCT00341159 is a clinical study titled "Analysis of Data From the Women's Contraceptive and Reproductive Experiences (CARE) Study". This study will continue to analyze data collected by the Women's Contraceptive and Reproductive Experiences (CARE) study. The CARE study was designed to evaluate the association between reproductive factors and risk of breast cancer in white and African-American women in the United States. The pre...
What is the current status of trial NCT00341159?
This trial is currently completed. The enrollment target is 9,257 participants. The study started on 2005-01-18. Estimated completion is 2015-02-24.
Who is sponsoring clinical trial NCT00341159?
This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.